Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,410
in 2 filings

Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lettmann Jason −$4K CHIEF EXECUTIVE OFFICER sold <1% of stake
  2. Wong Shelly −$1K SVP, FINANCE AND CAO sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2020-07-21 Lettmann Jason Director Conversion · Series A Convertible Preferred Stock −1,633,743 0
2020-07-21 Lettmann Jason Director Conversion · Series A Convertible Preferred Stock −222,752 0
2020-07-21 Lettmann Jason Director Conversion · Series A Convertible Preferred Stock −683,523 0
2020-07-21 Lettmann Jason Director Conversion · Series A Convertible Preferred Stock −39,758 0
2020-07-21 Lettmann Jason Director Conversion · Series B Convertible Preferred Stock −59,998 0
2020-07-21 Lettmann Jason Director Conversion · Series B Convertible Preferred Stock −8,175 0
2020-07-21 Lettmann Jason Director Conversion · Series B Convertible Preferred Stock −150,801 0
2020-07-21 Lettmann Jason Director Conversion · Series B Convertible Preferred Stock −11,110 0
2020-07-21 Lettmann Jason Director Conversion · Series C Convertible Preferred Stock −10,529 0
2020-07-21 Lettmann Jason Director Conversion · Series C Convertible Preferred Stock −137,286 0
2020-07-21 Lettmann Jason Director Conversion · Series C Convertible Preferred Stock −18,705 0
2020-07-21 Lettmann Jason Director Conversion · Series C Convertible Preferred Stock −664,660 0
2020-07-21 Lettmann Jason Director Conversion · Series C Convertible Preferred Stock −38,660 0
2020-07-21 Vivo Capital IX, LLC 10% owner Purchase +789,474 $19.00 $15.0M 789,474
2020-07-21 Vivo Capital IX, LLC 10% owner Conversion +3,245,048 4,034,522
2020-07-21 Vivo Capital IX, LLC 10% owner Purchase +185,526 $19.00 $3.5M 185,526
2020-07-21 Vivo Capital IX, LLC 10% owner Conversion · Series C Convertible Preferred Stock −3,158,851 0
2020-07-21 Graham G. Walmsley Director Conversion +2,105,901 2,161,981
2020-07-21 Graham G. Walmsley Director Purchase +975,000 $19.00 $18.5M 975,000
2020-07-21 Graham G. Walmsley Director Conversion · Series C Convertible Preferred Stock −2,105,901 0

Page 20 of 22 · 432 trades